Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, and SARS-CoV-2 and COVID-19 Research.
Correlates of HIV-1 control after combination immunotherapy
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies
Early biological markers of post-acute sequelae of SARS-CoV-2 infection
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019
Multiple early factors anticipate post-acute COVID-19 sequelae
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
HIV drug resistance in a community‐randomized trial of universal testing and treatment: HPTN 071 (PopART)
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084
Discovery of Quinoxaline-Based P1–P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States
Outcomes of donor-derived superinfection screening in HIV-positive to HIV-positive kidney and liver transplantation: a multicentre, prospective, observational study
LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers
Novel Method To Assess Antiretroviral Target Trough Concentrations Using<i>In Vitro</i>Susceptibility Data